# SteriBio Korea to build medical device plant in Namwon

SteriBio Korea, a Korean subsidiary of Chinese SteriBio, signed an investment agreement to build a factory in Namwon Industrial Complex. The company will invest 12 billion KRW to construct a plant on 15,510 m² for mass production of medical sterilizers and in vitro diagnostic kits by the first half of 2025.

- Type: New facility
- Announced: 2024-10-02
- Where: Namwon, Jeollabuk-do, South Korea
- Value: $9.00M (12.0B KRW)
- Starts operating: Jun 2025
- Status: announced
- Products: medical sterilizers, in vitro diagnostic kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [SteriBio Korea](https://endata.com/companies/80200.md)

## Sources

- [yna.co.kr](https://www.yna.co.kr/view/AKR20241002129300055), 2024-10-02: "이 업체는 중국 스터리바이오의 한국 법인으로, 내년 상반기까지 120억원을 들여 남원 일반산업단지 1만5천510㎡ 부지에 공장을 건립하고 의료기기 멸균처리기와 체외 진단키트를 양산할 예정이다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.